Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study

Affiliations

• ¹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ² Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ³ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁴ Dermatology Research Institute, Calgary, Alberta, Canada.
• ⁵ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Waterloo, Ontario, Canada.
• ⁶ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: jensen.yeung@utoronto.ca.